Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2001-11-06
2003-07-08
Huff, Sheela (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S142100
Reexamination Certificate
active
06589528
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a method for induction of differentiation of monocytes to osteoclasts, an agent comprising monoclonal antibody used for the above method, and a method for screening a ligand that induces differentiation of monocytes to osteoclasts.
BACKGROUND OF THE INVENTION
It is known that osteoclasts are multinucleated giant cells involved in bone resorption and have their origin in hematopoietic system (Udagawa, N. et al., Proc. Natl. Acad. Sci. USA 87: 7260-7264 (1990)). Although precise mechanisms for their differentiation and activation are not clear at present, osteoclasts are one of the most important factors that participate in the physiological metabolism of the bone and abnormality of these cells is related with osteoporosis. Formation of multinucleated cells induced by membrane fusion is the first step of formation of osteoclasts. Membrane fusion is an important process in biological phenomena (White, J. M., Annu. Rev. Physiol. 52: 675-697 (1990), Burger, K. N. and Verkleij, A., J. Experientia 46: 631-644 (1990)). Membrane fusion is also involved in fertilization, formation of muscles, exocytosis, endocytosis, formation of organella, and transport between intracellular organella. However, mechanisms that control membrane fusion is not well understood yet.
It has been reported that interstitial cells and steroids such as 1a, 25-dihydroxyvitamin D
3
or parathyroid hormone are necessary for formation of multinucleated osteoclasts caused by fusion of mononuclear cells of macrophages/monocytes (Takahashi, N. et al., Endocrinol. 122: 1373-1382 (1988), Takahashi, N. et al., Endocrinol. 123: 1504-1510 (1988), Quinn, J. M. W. et al., The Endocrin. Soc. 134: 2416-2423 (1991)). It has also been reported that several kinds of cytokines induce the formation of multinucleated cells from monocytes/macrophages (Lacey D. L. et al., Endocrinol. 136: 2367-2376 (1995), Murray G. R. J., Bone and Miner. Res. 8: S505-S510 (1993)). However, these methods do not clearly demonstrate that derived cells perform bone resorption. Furthermore, these methods require the presence of stroma cells and, thus, are not simple. There has been no report pertaining to a method of in vitro induction and differentiation of osteoclasts.
SUMMARY OF THE INVENTION
An object of the present invention is to provide a simple method for production of osteoclasts from monocytes, a agent comprising monoclonal antibody used in this method, and a method for screening of a ligand that induces differentiation of monocytes to osteoclasts. To achieve the object, the present inventors ardently studied and succeeded for the first time in differentiation of monocytes to osteoclasts in vitro by culturing isolated monocytes in the presence of monoclonal antibodies that bind to FRP-1 protein present on the surface of monocytes. Furthermore, the present inventors found that it was possible to isolate a ligand that binds to FRP-1 protein and induces differentiation of monocytes to osteoclasts with the use of the system for differentiation of monocytes to osteoclasts.
Thus, the present invention relates to a simple method for induction of differentiation of monocytes to osteoclasts using monoclonal antibody capable of inducing differentiation of monocytes to osteoclasts, an agent comprising the monoclonal antibody, and a method for screening a ligand that induces differentiation of monocytes to osteoclasts. More specifically, the present invention relates to
(1) a method of producing osteoclasts which comprises a step of contacting monocytes with monoclonal antibody that binds to a portion of FRP-1 protein exposed on the surface of monocytes;
(2) the method according to (1), wherein the osteoclasts are cells cultured in vitro;
(3) the in vitro cultured cells of osteoclasts obtainable by contacting monocytes with monoclonal antibody that binds to a portion of FRP-1 protein exposed on the surface of monocytes;
(4) the in vitro cultured cells according to (3), which is derived from human;
(5) an agent for inducing differentiation of monocytes to osteoclasts which comprises monoclonal antibody that binds to a portion of FRP-1 protein exposed on the surface of monocytes as an active ingredient;
(6) a method for screening a ligand that binds to FRP-1 protein, which comprises steps of treating monocytes with a test sample and detecting differentiation of monocytes to osteoclasts;
(7) a ligand that binds to FRP-1 protein and can be isolated by the method according to (6).
(8) the ligand according to (7), which is a naturally-occurring substance.
REFERENCES:
patent: 5196192 (1993-03-01), De Kretser et al.
Higuchi et al., “Formation of Osteoclasts from Blood Monocytes by Anti-Fusion Regulatory Protein-1/CD98 Monoclonal Antibody,”Journal of the Japanese Society for Bone and Mineral Research15(2):70 (1997).
Higuchi et al., “Induction of Human Osteoclast-like Cells by Treatment of Blood Monocytes with Anti-Fusion Regulatory Protein-1/CD98 Monoclonal Antibodies,”J. Bone Miner. Res.,13:44-49 (1998).
Ikegame et al., “Effects of Continuous Calcitonin Treatment on Osteoclast-Like Cell Development and Calcitonin Receptor Expression in Mouse Bone Marrow Cultures,”J. Bone Miner. Res.,11:456-465 (1996).
Kotake et al., “IL-17 in Synovial Fluids from Patients with Rheumatoid Arthritis Is a Potent Stimulator of Osteoclastogenesis,”J. Clin. Invest.,103:1345-1352 (1999).
Kukita et al., “Osteoclast-Like Cells Formed in Long-Term Human Bone Marrow Cultures Express a Similar Surface Phenotype as Authentic Osteoclasts,”Lab. Invest.,60:532-538 (1989).
Kurihara et al., “Identification of Committed Mononuclear Precursors for Osteoclast-Like Cells Formed in Long Term Human Marrow Cultures,”Endo.,126:2733-2741 (1990).
Kurihara et al., “Sequential Expression of Phenotype Markers for Osetoclasts During Differentiation of Precursors for Multinucleated Cells Formed in Lone Term Human Marrow Cultures,”Endo.,127:3215-3221 (1990).
Mbalaviele et al., “Osteoclast Formation from Human Cord Blood Mononuclear Cells Co-Cultured with Mice Embryonic Metatarsals in the Presence of M-CSF,”Bone16:171-177 (1995).
MacDonald et al., “Formation of Multinucleated Cells that Respond to Osteotropic Hormones in Long Term Human Bone Marrow Cultures,”Endo.,120:2326-2333 (1987).
Matsuzaki et al., “Osteoclast Differentiation Factor (ODF) Induces Osteoclast-Like Cell Formation in Human Peripheral Blood Mononuclear Cell Cultures,”Biochem. Biophys. Res. Commun.,246:199-204 (1998).
Matsuzaki et al., “Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene,”Endo.,140:925-932 (1999).
Miyahara et al., “Effects of Lead on Osteoclast-Like Cell Formation in Mouse Bone Marrow Cell Cultures,”Calcif. Tissue Int.,54:165-169 (1994).
Ohgimoto et al., “Molecular Characterization of Fusion Regulatory Protein-1 (FRP-1) that Induces Multinucleated Giant Cell Formation of Monocytes and HIV gp160-Mediated Cell Fusion,”J. Immunol.,155:3858-3592 (1995).
Okamato et al., “Paramyxovirus-Induced Syncytium Cell Formation Is Suppressed by a Dominant Negative Fusion Regulator Protein-1 (FRP-1)/CD98 Mutated Construct: An Important Role of FRP-1 in Virus-Induced Cell Fusion,”J. Gen. Virol.,78:775-783 (1997).
Purton et al., “Normal Human Peripheral Blood Mononuclear Cells Mobilized with Granulocyte Colony-Stimulating Factor Have Increased Osteoclastogenic Potential Compared to Nonmobilized Blood,”Blood87:1802-1808 (1996).
Quinn et al., “Rodent Osteoblast-Like Cells Support Osteoclastic Differentiation of Human Cord Blood Monocytes in the Presence of M-CSF and 1,25 Dihydroxyvitamin D3,”Int. J. Biochem. Cell. Biol.,29:173-179 (1997).
Quinn et al., “Human Osteoclast Formation from Blood Monocytes, Peritoneal Macrophages, and Bone Marrow Cells,”Calcif. Tissue Int.,62:527-531 (1998).
Ransjö et al., “Cholera Toxin and Forskolin Stimulate Formation of Osteoclast-Like Cells in Mouse Marrow Cultures and Cultured Mouse Calvarial Bones,”Eur. J. Oral. Sci.,107:45-
Higuchi Shigeomi
Ito Yasuhiko
Clark & Elbing LLP
DNAVEC Research Inc.
Huff Sheela
LandOfFree
Method for induction of differentiation of osteoclasts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for induction of differentiation of osteoclasts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for induction of differentiation of osteoclasts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3011824